MedTrace Logo

An International Multicenter Study on Transcatheter Device Closure of Perimembranous Ventricular Septal Defects

NCT06823635 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-02-12

No results posted yet for this study

Summary

The international multicenter registry aims to gather real-world data on patient outcomes and assess the procedural success and performance of various device occluders used in the transcatheter treatment of pediatric and adult patients with perimembranous ventricular septal defects (PmVSD).

Conditions

  • Perimembranous Ventricular Septal Defect

Interventions

DEVICE

Transcatheter device closure of perimembranous ventricular septal defects (PmVSDs)

Transcatheter closure of perimembranous ventricular septal defects (PmVSDs) using an occluder device either specifically designed for this purpose or used off-label.

Sponsors & Collaborators

  • Fondation Hôpital Saint-Joseph

    lead OTHER

Principal Investigators

  • Raymond N. Haddad, MD, MHSc · Marie Lannelongue Hospital

Eligibility

Min Age
3 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-01
Primary Completion
2026-07-31
Completion
2026-07-31

Countries

  • Denmark
  • France
  • Germany
  • Indonesia
  • Iran
  • Lebanon
  • Mexico
  • Pakistan
  • Poland
  • Saudi Arabia
  • Turkey (Türkiye)
  • United Arab Emirates

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06823635 on ClinicalTrials.gov